4:50 PM
Feb 24, 2010
 |  BC Extra  |  Company News

FDA accepts lorcaserin NDA

FDA accepted for filing an NDA from Arena Pharmaceuticals Inc. (NASDAQ:ARNA) for lorcaserin for...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >